Quantum-Si Announces Successful Sequencing on Integrated Proteus(TM) Instruments

Stock Information for Quantum-Si Incorporated

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quantum-Si Incorporated

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus(TM) Development Milestones
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Announces First Customer Samples Tested on the Proteus(TM) Prototype System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.